Sight Diagnostics is a medical device company developing a novel platform for diagnosing blood diseases using computer vision technology.
SightDx's detection technology combines cutting edge applications from the fields of computer hardware, software and biology to deliver the fastest and most accurate diagnostic performance.
SightDx's flagship product, Parasight, identifies, enumerates and speciates malaria more accurately than all other currently used diagnostics. In the future, SightDx's platform technology will be used to identify additional anomalies in blood and body fluids.
Skylimit (IsraelExporter parent company) recently helped Sight Diagnostics enter the Nigerian market.
Video - Sight Diagnostics Recommending Skylimit Services